# Discontinuation of Antiviral Therapy as a Strategy to Cure Hepatitis B

> **NCT05328427** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Göteborg University** · enrollment: 33 (actual)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

- **OTHER:** Stopping

## Key facts

- **NCT ID:** NCT05328427
- **Lead sponsor:** Göteborg University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-11-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2025-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05328427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05328427, "Discontinuation of Antiviral Therapy as a Strategy to Cure Hepatitis B". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05328427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*